|
a |
|
b/man/data-cytokineViab.Rd |
|
|
1 |
\name{cytokineViab} |
|
|
2 |
\alias{cytokineViab} |
|
|
3 |
\docType{data} |
|
|
4 |
\title{ |
|
|
5 |
Response of CLL to exposure to cytokines |
|
|
6 |
} |
|
|
7 |
\description{ |
|
|
8 |
The data set include the response measurements of 18 CLL patient samples exposed to six cytokines: IL-2, IL-10, IL-4, IL-21 (c1=0.001, c2=0.1, c3=10 ng/ul), LPS (c1=1, c2=10, c3=100 ng/ul) and IgM (c1=10 nM, c2=1, c3 = 10 uM) for 48 hours. Viability was measured using a CellTitre Glo assay, and luminescence was normalized to unstimulated controls. The results were stored in a tidy table (tibble) with 11 columns: |
|
|
9 |
'Patient' is a patient sample ID, |
|
|
10 |
'Timepoint' is a screening timepoint (48 h), |
|
|
11 |
'Recording_date' is a date when the measurements were collected, |
|
|
12 |
'Seeding_date' is a date when the experiment was started, |
|
|
13 |
'Stimulation' is a name of cytokine used, |
|
|
14 |
'Cytokine_Concentration' is a concentration of cytokine, |
|
|
15 |
'Duplicate' is an information about the duplicates, |
|
|
16 |
'Normalized_DMSO' is a drug response value after normalization by untreated control, |
|
|
17 |
'mtor' is an information on whether the sample was classified into mtor group by our study, |
|
|
18 |
'Edge' is an information of the position of the well respective to the whole screening plate, |
|
|
19 |
'Cytokine_Concentration2 is again the concentration of the cytokine but in a different format. |
|
|
20 |
} |
|
|
21 |
\author{Sascha Dietrich, Małgorzata Oleś} |
|
|
22 |
\usage{ |
|
|
23 |
cytokineViab |
|
|
24 |
} |
|
|
25 |
\format{ |
|
|
26 |
tibble with 324 rows and 11 columns. |
|
|
27 |
} |
|
|
28 |
\keyword{datasets} |